Kolexia
Makhloufi-Martinage Samira
Oncologie médicale
Clinique Saint-hilaire Rouen
Rouen, France
38 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Métastase tumorale Tumeurs colorectales Tumeurs de la tête et du cou Tumeurs du foie Tumeurs du pancréas Tumeurs de la prostate Carcinome épithélial de l'ovaire Carcinomes Tumeurs du rachis

Industries

Gilead
6 collaboration(s)
Dernière en 2023
MSD
4 collaboration(s)
Dernière en 2022
Ipsen
3 collaboration(s)
Dernière en 2023
Daiichi Sankyo
2 collaboration(s)
Dernière en 2022

Dernières activités

CHIPPI: Phase III Randomized Clinical Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer Considering Two Different Settings: Primary Debulking Surgery (PDS) and Interval Debulking Surgery (IDS)
Essai Clinique (Centre Oscar-Lambret)   06 décembre 2022
952P Neutrophil-to-lymphocyte ratio (NLR) and survival in recurrent or metastatic head and neck cancer patients treated with immunotherapy
Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020   01 septembre 2020
Docetaxel (DOC) versus new androgen receptor-targeted agent (ART) in metastatic castrate-resistant prostate cancer (mCRPC) patients (pts) having received abiraterone (ABI) or enzalutamide (ENZA) as first-line (L1).
2020 Genitourinary Cancers Symposium   19 février 2020
Fong's Score in the Era of Modern Perioperative Chemotherapy for Metastatic Colorectal Cancer: A Post Hoc Analysis of the GERCOR-MIROX Phase III Trial.
Annals of surgical oncology   22 octobre 2019
Who can benefit from a liver surgery for metastatic colorectal cancer in the era of modern chemotherapy? A post hoc analysis of the MIROX phase III trial.
2019 ASCO Annual Meeting I   26 mai 2019
Efficacy and Tolerance of Post-operative Hypo-Fractionated Stereotactic Radiotherapy in a Large Series of Patients With Brain Metastases.
Frontiers in oncology   28 mars 2019
Prognostic impact of the neutrophil-to-lymphocyte ratio (NLR) on overall survival in patients treated with chemoradiotherapy for head and neck cancer
Abstract Book of the 42nd ESMO Congress (ESMO 2017) 8-12 September 2017, Madrid, Spain   01 septembre 2017
Bevacizumab Associated with Chemotherapy for Initially Non-resectable Liver Metastases from Colorectal Cancer: a Case-Control Study.
Anticancer research   08 février 2017
Deep Vein Thrombosis: An Independent Poor Prognosis Factor of Advanced Pancreatic Adenocarcinoma.
Anticancer research   08 février 2017
Stereotactic body radiation therapy for spinal metastases.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   07 septembre 2016